Diagnostic Imaging’s Weekly Scan: March 29 — April 4

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

Over a 10-year period, radiology report turnaround times for Medicare beneficiaries increased 113 percent with a total 87 percent increase occurring in 2022 and 2023, the last two years of a newly published retrospective study.

In a recent interview with Diagnostic Imaging, James Nagarajah, M.D., discussed new phase 2 research demonstrating significantly delayed disease progression in a cohort of patients with oligometastatic hormone-sensitive prostate cancer treated with 177Lu-PSMA-617 and complete remission in nearly a quarter of these patients.

For people with a history of heavy smoking, detection of significant incidental findings (SIFs) on low-dose computed tomography (LDCT) screening scans was associated with a 13.89 per 1000 marginal risk difference for extrapulmonary cancer in contrast to those with no SIFs, according to a study involving over 26,000 people.

For patients with prostate cancer (PCa) being considered for a radical prostatectomy, a new meta-analysis demonstrates that pre-op MRI findings of extraprostatic extension (EPE) and seminal vesicle invasion (SVI) are associated with significantly elevated risks of biochemical recurrence (BCR) and metastatic failure.

In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, and Marla Sammer, MD, discussed the dearth of AI applications for pediatric imaging, new research evaluating adjunctive AI triage for CT detection of intracranial hemorrhages in children six and older, and going beyond the data points to ascertain the impact of AI on patient care.

Thank you for checking out the latest edition of Diagnostic Imaging’s Weekly Scan.